600176 how about this one?

600176 this is not good, from the perspective of long-term investment, the fundamentals of this stock are not good, the price-earnings ratio is very high, there is no profit for several years, and there are losses, this stock is not worth long-term investment.

From the point of view, from the trend point of view, this stock is a line of white road blue sky, has been at a high level, at any time there is a possibility of **, under the favorable US monetary policy, two consecutive days of underperformance, obviously the offensive is weak.

But now ** is good, those who dare may wish to give it a try.

Personal opinion, just for reference!

The company is mainly engaged in the production and sales of glass fiber and products, and is the largest manufacturer of glass fiber and products in China. The company's glass fiber business is mainly completed through its holding subsidiary, Jushi Group. Jushi Group's production scale of glass fiber and products ranks first in Asia, is one of the monopoly giants in the industry, and is also a national large enterprise and a key high-tech enterprise of the National Torch Program.

Glass fiber has excellent properties and a wide range of uses, and has become an indispensable raw material in construction, transportation, electronics, electrical, chemical, metallurgical and other fields. It is estimated that the company's EPS per share in 2010-2012 will be , , respectively. Gives the company an "overweight" rating.

The conclusion of the research report of other companies is similar, and the target position is given an additional 30 yuan. The space does not seem to be very large, and the recent large orders show that there are signs of main distribution, and it is estimated that there are individual ** reductions. Therefore, it is recommended to wait for ** to intervene later, and if there is, you can also consider partial distribution and make a short difference.

If you're going to sell this ** ticket, I'd say you're doing it right.

If you want to buy this ** ticket, I will say why did you come earlier? I can't buy it anymore.

If you want to make money, you can't see which one goes up, you can buy it, and anyone will look at it, so you can't make money, you have to look for something that can rise in the future and hasn't risen yet.

It is still an upward trend and can continue to be held.

There is a ** adjustment in the short term.

In the short term, it may be necessary to consolidate or move sideways in two weeks.

Tianjin Port! Grasp it well, any ** is good!!

Take a look at the picture! Here's the daily chart!

When the auction was opened on September 10, the executives were on the high for a few days, and it was stupid!

Due to the executive running away, this wave of **** ended!

This day also drives high and goes low! Hit the price limit several times!!

I have to say that the executives' guesses are endless! Stop the trend of ** alive!

The interval statistics have fallen so far, and one share has fallen by 6 cents and 3! It doesn't seem like much! But this is a penny stock!!

It's not yet a bookmaker with a high degree of control! It's all trapped on top! It's all a small scatter!

And there is a lot of money!

This is the plate!

**It's the story of spike bending! It's all for you to amuse!

It is an important port! Of course, it's also an outlet!!

That's the heart of the story! I don't know when a story will be up and down instantly! That's the charm of the story!

What Xiaosan can do is to follow the trend!! Don't see the rabbit and don't scatter the eagle!!

600516 is Fangda Carbon**.

1. The company's original name is Lanzhou Hailong New Material Technology Co., Ltd., which was approved by Gansu Provincial People's ** Gan Zhenghan [1998] No. 87 on December 16, 1998 and Gansu Provincial Economic System Reform Commission Gan Ti Gaifa [1998] No. 76 on December 24, 1998. Lanzhou Kejin Technology Co., Ltd. jointly initiated the establishment of shares****.

2. Business scope of graphite and carbon new materials development, scientific and technological research and development, technology promotion, production and processing, wholesale and retail; research and development, scientific and technological research and development, technology promotion, production and processing, wholesale and retail of carbon fiber, special carbon products, high-purity graphite products, carbon-carbon composite materials, lithium-ion battery anode materials; R&D, production, sales and technical services of graphene and downstream products; R&D, production and sales of graphene functional masks; Operate the import and export business of the company's own products and technologies; Operate the import and export business of raw and auxiliary materials, machinery and equipment, instruments, spare parts and technologies required for the production of the enterprise (except for varieties restricted by the state).

Extended information: 1. From the company's point of view.

As a leading enterprise in the industry, Fangda Carbon has better and better development prospects in the industry change, and the development momentum is good, and the future is worth looking forward to. The world's best production base of high-quality carbon products and scientific research and production base of nuclear-related carbon materials. The production and sales of large carbon, graphite, carbon products and special mineral powder are the key businesses.

For example, metallurgy, chemical and other industries and high-tech fields have been applied on a large scale. It is a leading enterprise in the domestic carbon industry.

Second, from the perspective of the industry.

The industry is still in the stage of decentralized competition, but due to market, policy, capital, environmental protection and other factors, small and medium-sized enterprises are gradually abandoned. The national policy puts forward relevant requirements, and the increase in the market share of electric furnace steel will increase the market demand for ultra-high power graphite electrodes. In addition, after the epidemic, the resumption of work and production, the downstream market is good.

The sales volume of the company's graphite electrode products have increased. This shows that the concentration of the carbon industry and the company's performance need to be improved. In addition, the company is actively developing new carbon materials, completely breaking the foreign monopoly technology, and the company's industry competition has also improved slightly.

The industry-leading Fangda Carbon will be the first to enjoy the dividends of industry development. As a leading enterprise in the industry, Fangda Carbon is expected to have better and better development prospects in the industry change.

601868 can't be said to be a leading stock, only a good stock.

China Energy Construction: 601868 is a comprehensive service provider that provides overall solutions and whole industry chain services for global energy, power, infrastructure and other industries. In the brand, the organization.

The platform and other aspects are highly competitive. The current price is yuan, with a total market value of 115.5 billion yuan and a dynamic price-earnings ratio of 25 times.

Also recommended: PowerChina: 601669

The leader of the global hydropower and wind power construction model. The company has steadily promoted the power investment business with clean energy such as wind power, solar photovoltaic power generation, and hydropower as the core, with an installed wind and solar capacity of 10,000 kilowatts. The current price is yuan, with a total market capitalization of 116.4 billion yuan and a dynamic price-earnings ratio of 13 times.

Chinese Chemistry: 601117

In the field of chemical engineering, it has always been in the leading position in the domestic industry. The company has been in the field of complete competition, is the leader of the chemical industry industry segment, the long-term struggle in the market has created a strong sense of market competition, and the technology is leading. The current price is yuan, with a total market capitalization of 76.6 billion and a dynamic price-earnings ratio of 19 times.

Northeast Moutai Changchun High-tech 000661 is in an eventful autumn. Jin Lei, general manager of Jinsai Pharmaceutical, made the company's stock price **14%, and the market value evaporated by more than 20 billion yuan. Exchanges are just a catalyst for ******.

The real determining factor is the company's long-term good foundation. Although Changchun High-tech started in real estate, Kinsey Pharmaceutical's biological gene products have long been the absolute pillar of the company's performance. Changchun High-tech's main business is the research and development, production and sales of biopharmaceuticals and Chinese patent medicines, supplemented by real estate development, property management and services.

Pharmaceutical products cover many pharmaceutical subdivisions such as innovative genetic engineering pharmaceuticals, new vaccines, and traditional Chinese medicine, which are the main products of the company's performance.

Growth hormone, a major product of Kinsey Pharmaceutical, also occupies the leading position. Its high-growth attributes make the growth rate data of Changchun High-tech, a listed company, quite good. Investors are re-viewing Changchun High-tech as a biomedical company, rather than a mixed real estate and biomedical company with chaotic governance, which opens up valuation space for Changchun High-tech.

Changchun High-tech**, it is rumored that the production of human hormones in the restructured core industry should be included in the centralized collection, mainly powder injection. Even if the powder injection is included in the centralized procurement, it will have little impact on the profit of Changchun High-tech, because the original proportion is not high; Shareholder Jin Lei reduced his shareholdings. It's actually hype expectations.

Changchun High-tech is expected to be poor in the short and medium term, and the POPS stock price is **. The key to this correction is when it bottoms out. For example, wait until "China**" comes out to verify.

If it hits rock bottom, it is indeed a good opportunity from the company's fundamentals. From the perspective of the disk, small and medium-sized market capitalization stocks such as technology stocks have recently shown obvious signs of stabilizing the bottom, and the leaders of some sub-sectors have been steadily **. The persistence of this ** needs to be observed for some time.

As the second largest shareholder of Changchun High-tech, Jin Lei will be the first shareholder at the end of the year, because he needs to pay 1 billion yuan in taxes. Since its establishment, Kinsey Pharmaceutical has been controlled by Changchun High-tech, which is a core subsidiary of Changchun High-tech.

It is very unstable, it is not worth starting, and now the volatility of ** is very large, and it is very likely to lose a lot of money.

This is a very good **, many people have already bought it now, and it has also received a good response, and it is worth starting.

This one** is very good. It's not worth starting, because the market is very turbulent right now, and many** are losing money.

Summary. Dear, hello, in the vast sea of people, I am honored to answer your questions, I am Wenqutang Financial Research, please wait, I am looking at your question, I will reply to you immediately, please wait a while Thank you<>

Dear, hello lead imitation of the fu, in the vast sea of people, it is an honor to answer your questions, I am Wenqutang financial research wheel, please wait, I am looking at your question, I will reply to you immediately, please wait a while Thank you<>

Dear, the New Year is auspicious, hello, the beginning of 600** in the yuan is: 600999 investment**, just a <>

600999 After more than ten years of entrepreneurial development, the company's capital strength has been ranked among the top three in the industry, with a registered capital of 100 million yuan and a total number of employees of 2,000 people.

Founded in 1991, the company is based on the development and growth of the bank of China Merchants Chendan Bank's securities business and securities business. <>

Dear, I wish you all the best in 2022! Good luck for the whole family! <>

Please also give a 5-star thumbs up, thank you! Welcome to follow me, I will answer the spine in the column of Baijiahao**, banking, insurance and other financial issues! Wenqu number of Xiaotang financial research in the distance deep - I wish you a happy day! Thanks! <>

600910 is not, in China's **market, including U.S. stocks and **, there is no query for 600910 this **ticket**, which proves that this ** is not available for listed companies to use. 600910's ** is a platform to publicize the "Minxiang Mining Group", you can log in to the "National Enterprise Credit Credit Doula Base Information Publicity System", Tianyan Check, Enterprise Check, Qixinbao Central Bureau Query, it is not possible to find this company.

It is a part of the ownership of the joint-stock company, and it is also a certificate of ownership issued by the joint-stock company to each owner as a shareholding certificate in order to raise funds and obtain dividends and bonuses.

**It is a long-term credit instrument in the capital market, which can be transferred, bought and sold, and shareholders can share the company's profits with it, but also bear the risk caused by the company's operating errors. Each share** represents a shareholder's ownership of a basic unit of the business. Every public company will issue a **.

**It has the characteristics of high return and high risk, so when screening**, you must be more cautious and more attentive. You need to be clear about which investment method is more suitable for you, whether it is **, medium-term, or long-term.